|
Status |
Public on Jun 08, 2021 |
Title |
RET44 |
Sample type |
genomic |
|
|
Source name |
rectal adenocarcinoma
|
Organism |
Homo sapiens |
Characteristics |
response: pCR
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA was extracted and purified from pre-treatment biopsies of rectal tissue using a phenol-chloroform-isoamyl alcohol (25:24:1) solution-based protocol.
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human MethylationEPIC Beadchip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using the Illumina HiScan system with the standard recommended Illumina scanner setting
|
Description |
naive biopsies
|
Data processing |
data were processed using R language. Briefly, β values were normalized and batch effects were removed. Probes with low quality (detection p-value >0.05), mapped in X/Y chromosomes and cross-reactive were filtered out, as previously described by Pidsley R et al. (2016 - DOI: 10.1186/s13059-016-1066-1)
|
|
|
Submission date |
Jun 13, 2019 |
Last update date |
Jun 08, 2021 |
Contact name |
Luisa Matos do Canto |
Organization name |
Vejle Hospital
|
Department |
Biochemistry and Immunology
|
Street address |
Beriderbakken 4
|
City |
Vejle |
ZIP/Postal code |
7100 |
Country |
Denmark |
|
|
Platform ID |
GPL23976 |
Series (1) |
GSE132668 |
DNA methylation-based classifier to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal carcinomas. |
|